Accuray Incorporated (ARAY)
Market Cap | 204.15M |
Revenue (ttm) | 444.20M |
Net Income (ttm) | -16.53M |
Shares Out | 100.57M |
EPS (ttm) | -0.17 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 570,092 |
Open | 2.090 |
Previous Close | 2.070 |
Day's Range | 2.010 - 2.100 |
52-Week Range | 1.400 - 3.050 |
Beta | 1.46 |
Analysts | Strong Buy |
Price Target | 9.00 (+343.35%) |
Earnings Date | Jan 29, 2025 |
About ARAY
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, a... [Read more]
Financial Performance
In 2024, Accuray's revenue was $446.55 million, a decrease of -0.24% compared to the previous year's $447.61 million. Losses were -$15.55 million, 67.5% more than in 2023.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for ARAY stock is "Strong Buy" and the 12-month stock price forecast is $9.0.
News
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis. , Nov. 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy, the company's new Vice P...
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
Accuray Reports Fiscal 2025 First Quarter Financial Results
Strong Start to Fiscal Year, Raises 2025 Guidance MADISON, Wis. , Nov. 6, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended Septembe...
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference ...
Accuray Appoints Michael Murphy as VP, Corporate Controller
MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller.
Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
MADISON, Wis. , Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her fu...
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in...
Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments MADISON, Wis. , Sept. 10, 2024 /PRNewswire/ -- Accuray Incorpo...
Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of ...
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strate...
Accuray Remains A Perpetual 'Next Year Is Our Year' Story
Accuray posts a strong end to the fiscal year with 16% revenue growth in FQ4, beating expectations and restoring some confidence for the upcoming year. Management's claim that weaker U.S. sales are a ...
Accuray Incorporated (ARAY) Q4 2024 Earnings Call Transcript
Accuray Incorporated (NASDAQ:ARAY) Q4 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Per...
Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results
14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wis. , Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth q...
Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology
New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments MADISON, Wis. and DAYTONA BEACH, Fla.
Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024
MADISON, Wis. , July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024, during a conference cal...
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
The Radixact System will be supplied with ClearRT®, Synchrony®, and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized w...
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-p...
Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision ® Treatment Planning System (TPS) has been app...
Accuray to Participate in the Jefferies Global Healthcare Conference 2024
MADISON, Wis. , May 22, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024.
Accuray Incorporated (ARAY) Q3 2024 Earnings Call Transcript
Accuray Incorporated (NASDAQ:ARAY) Q3 2024 Earnings Conference Call May 1, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pervaiz...
Accuray Reports Fiscal 2024 Third Quarter Financial Results
MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024.
Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis. , April 25, 2024 /PRNewswire/ -- Ac...
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin (U.S.), Tokyo, Japan and Tianjin, China Each facility offers a range of educational opportunit...
Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
MADISON, Wis. , April 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024, during a conference ca...
Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp
Despite management guidance that points to significant revenue acceleration in the next two quarters, Accuray shares have languished. Market skepticism can be tied in part to the company's track recor...